Muscle wasting in animal models of severe illness
Author:
- 8 May 2012
- journal article
- review article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 93 (3) , 157-171
Abstract
Summary: Muscle wasting is a serious complication of various clinical conditions that significantly worsens the prognosis of the illnesses. Clinically relevant models of muscle wasting are essential for understanding its pathogenesis and for selective preclinical testing of potential therapeutic agents. The data presented here indicate that muscle wasting has been well characterized in rat models of sepsis (endotoxaemia, and caecal ligation and puncture), in rat models of chronic renal failure (partial nephrectomy), in animal models of intensive care unit patients (corticosteroid treatment combined with peripheral denervation or with administration of neuromuscular blocking drugs) and in murine and rat models of cancer (tumour cell transplantation). There is a need to explore genetically engineered mouse models of cancer. The degree of protein degradation in skeletal muscle is not well characterized in animal models of liver cirrhosis, chronic heart failure and chronic obstructive pulmonary disease. The major difficulties with all models are standardization and high variation in disease progression and a lack of reflection of clinical reality in some of the models. The translation of the information obtained by using these models to clinical practice may be problematic.Keywords
This publication has 145 references indexed in Scilit:
- BCATm deficiency ameliorates endotoxin-induced decrease in muscle protein synthesis and improves survival in septic miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Modulation of Muscle Atrophy, Fatigue and MLC Phosphorylation by MuRF1 as Indicated by Hindlimb Suspension Studies on MuRF1-KO MiceJournal of Biomedicine and Biotechnology, 2010
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic CancerScience, 2009
- Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunctionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Local insulin-like growth factor I prevents sepsis-induced muscle atrophyMetabolism, 2009
- Protein metabolism in slow‐ and fast‐twitch skeletal muscle during turpentine‐induced inflammationInternational Journal of Experimental Pathology, 2007
- Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary diseaseThorax, 2007
- Curcumin prevents lipopolysaccharide‐induced atrogin‐1/MAFbx upregulation and muscle mass lossJournal of Cellular Biochemistry, 2006
- Modulation of inflammatory response in sepsis by proteasome inhibitionInternational Journal of Experimental Pathology, 2006
- Cachexia in cancer patientsNature Reviews Cancer, 2002